Passage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

PHILADELPHIA, April 22, 2024 -- Passage Bio, Inc. , a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that...

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Mike Beyer ,Stuart Henderson ,William Chou ,Eden Fucci ,Nasdaq ,Passage Bio Inc ,Sam Brown Inc ,Healthcare Communications ,Annual Genetic Medicines ,Cell Therapy Manufacturing Summit ,Passage Bio ,Bio Media ,Markets ,